NCT04998370View on ClinicalTrials.gov

Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury

Active, not recruitingOBSERVATIONAL
Enrollment

409

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

October 31, 2024

Conditions
Subarachnoid Hemorrhage, AneurysmalVasospasmDelayed Cerebral IschemiaDelayed Ischemic Neurological Deficit
Trial Locations (8)

1090

Medizinische Universität Wien, Klinik für Neurochirurgie, Vienna

4040

Johannes Kepler Universität Linz, Universitätsklinik für Neurochirurgie, Linz

8091

University Hospital Zurich, Zurich

68167

Universitätsklinikum Mannheim, Mannheim

72076

Universitätsklinikum Tübingen, Tübingen

81675

Klinikum rechts der Isar TUM, München

CH-5001

Kantonsspital Aarau, Aarau

CH-9007

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

University of Zurich

OTHER